Xing Ling

 

Spearheading the Global Expansion of China's Top Pharma & TCM Firms
把中国顶尖药品推向世界

Home

About Us Contact Us Links FAQ  DISTRIBUTORS WANTED  


Traditional Chinese Medicine
GuiLingJi
DingKunDan
YuPingFeng
BanLanGen
Cooling & Detox Liquid
WuJiBaiFengWan
ShengTianQiPian
YinQiaoJieDuPian
JingZhiGuanXinPian
HuGanNingPian
FuFangDanShenPian
XiaoYaoWan
HuoXiangZhengQiWan
GuiPiWan
QiJuDiHuangWan
ShiQuanDaBuWan
JinSuoGuJingWan
LiuWeiDiHuangWan
BuZhongYiQiWan
ShuJinHuoXuePian
HouTouJunPian

Scientific Chinese Medicine                  
Kardigen
Mobix
Dioscornin
Livotide

Supplements  
Cartrix-M

Treated Herbs
Herb Library

Western Drugs

Watch TV Ads
(in Chinese)
GuiLingJi
RuiZhu Eyedrops

Distributors Wanted


 

 


ABOUT US


Xing Ling International is a Singapore-based global exclusive representative for large Chinese pharmaceutical groups, distributing a reputable range of Chinese and Western medicine. The company has secured global representation rights from top pharmaceutical & Traditional Chinese Medicine (TCM) companies in China, the most significant of which are the Topsun and Kinna Groups.  

Our key principal, the Topsun Group, is one of the largest privately-owned pharmaceutical enterprise in China, with a turnover of RMB 2 billion (US$248 million) in 2004. The Group operates 19 factories boasting current Good Manufacturing Practices (cGMP) certifications and has a 10,000-strong workforce. Topsun produces a massive range of heritage TCM formulations and cost-effective Western generic drugs including antibiotics, anti-hypertensives, opthalmics and biologics.

 

In 2005, Xing Ling acquired Teleios Pharma ("Teleios"), making Teleios a wholly-owned subsidiary of Xing Ling. Teleios will continue to market its range of Western supplements under the 'Teleios Pharma' brand.

 

Xing Ling is part of Orchid Capital Limited, a listed entity in Australia and Germany. This puts us on fast track towards fulfilling our mission of global expansion for the rapidly growing TCM and Western Generics markets.

 

We are actively looking for strategic distribution partners from anywhere around the world to market and distribute our unique product portfolio. We also welcome established suppliers who can further add to our range of products. Xing Ling is not a trading company but owns its product brands, and develops marketing concepts catering to various markets all over the world, to bring the intellectual wealth of 3,000 years of Chinese medical benefits closer to mankind. Please contact our Product Director Ms Gloria Seow at gloria_seow@xing-ling.com to find out more about distribution opportunities.

 

 

 

 

MANAGEMENT TEAM
 


The management team of Xing Ling International has significant experience in the areas of pharmaceutical products, marketing and sales, product distribution and financial management. Below are the key personnel of the management team:

 

Julian Sandt - Chairman

julian_sandt@xing-ling.com


Mr Sandt has an MBA from the Koblenz Business School in Germany and has held various positions with Commerzbank in Europe and Singapore between 1994 to 2000. His last held position with the bank was Manager, Capital Markets and Syndications. In 2000-2003, he was Managing Partner at TFG Venture Capital (Asia) Pte Ltd in Singapore. In 2004-2005, he became Senior Partner with Aegis Private Capital Pte Ltd in Singapore. Since Sept 2005, Mr Sandt has been the CEO of Orchid Capital Ltd, Xing Ling's parent company.

 

 

Erik Ng - Managing Director

erik_ng@xing-ling.com

 

Mr Ng has more than 10 years of sales and marketing experience in Singapore's pharmaceutical sector, having worked with medical giants like Pfizer and Novartis. From 1995-1999, he was a sales representative at Pfizer, marketing both patent and off-patent medicine to general practitioners, specialists, surgeons, hospitals and pharmacies. He played a part in successful product launches including blockbusters like Viagra. During his tenure with Novartis from 2000-2004, he was involved in budget planning, sales projections, market analysis, A&P Planning, ROI calculations, stock rolling forecasts, merchandising, monitoring SKU profitability, staff training and logistics coordination. He was also instrumental in Novartis's key account management programme and was in charge of liaising with key distributors. In 2004, he joined Apricot Distribution Network as Executive Director and was involved in both local and overseas strategic partnership development ventures. Today, he manages Xing Ling's local and overseas business development portfolio, runs the sales and marketing team, as well as manages the overall operations of the company.

 

 

Gloria Seow - Product Director

gloria_seow@xing-ling.com

Ms Seow graduated with a Bachelor of Arts in Mass Communications and Psychology from the National University of Singapore in 1995. From 1995-2003 she was involved in corporate and marketing communications work and was also the editor of a regional publication. Ms Seow founded Teleios Pharma in 2002, a Singapore based company that dealt with pharmaceutical and supplements distribution to the Western medical sector. In September 2004, she joined Apricot Distribution Network as Product Manager, marketing its range of supplements to general practitioners and pharmacies while continuing to run Teleios Pharma. Teleios was acquired by Xing Ling in 2005. Today, she is in charge of Xing Ling's product development portfolio, in terms of marketing and re-branding these products to suit local and overseas distribution. She also handles all product registration matters.

 

 

© Copyright 2005-2006 Xing Ling International Pte Ltd. All Rights Reserved.
66 Tannery Lane #01-05A Sindo Building Singapore 347805    Tel: (65) 6100-1707    Fax: (65) 6741-1007  
 gloria_seow@xing-ling.com